Institutional Development Award (IDeA) for Clinical & Translational Research (CTR)
Grant Opportunity Analysis
The National Institutes of Health (NIH) is offering the Institutional Development Award (IDeA) for Clinical & Translational Research (CTR), aimed at enhancing biomedical research capacity in states with historically low NIH funding. This grant program supports two tracks: the IDeA Clinical and Translational Research Development (CTR-D) awards, which focus on workforce development and infrastructure enhancement, and the IDeA Clinical & Translational Research Network (CTR-N) awards, which aim to build statewide or multi-state networks to improve clinical research capabilities. This initiative is crucial for addressing health challenges prevalent in IDeA states, which include Alaska, Arkansas, and others, and is open to private institutions of higher education that meet specific eligibility criteria. Interested applicants can reach out to NIGMS IDeA CTR via email at NIGMS_IDeA-CTR@mail.nih.gov for further information, with the estimated project start date set for July 16, 2027, and the application deadline anticipated to close on October 9, 2026.
Eligible Applicants
Eligibility is restricted to institutions that meet the following criteria:Are located in an IDeA-eligible state, commonwealth, or jurisdiction, which are Alaska, Arkansas, Delaware, Hawaii, Idaho, Kansas, Kentucky, Louisiana, Maine, Mississippi, Montana, Nebraska, Nevada, New Hampshire, New Mexico, North Dakota, Oklahoma, Puerto Rico, Rhode Island, South Carolina, South Dakota, Vermont, West Virginia, and Wyoming; andAward doctoral degrees in the health-related sciences or are independent biomedical research institutes/medical centers with ongoing biomedical research programs funded by the NIH or other federal agencies.